FindTrial
Sign In

Role of Ayurveda therapy on inflammation in Human Body

Effect of Shodhananga Snehapana with Muchita Grita and Panchatikta guggulu Ghirta on Inflammatory Biomarkers during Virechana An exploratory Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111788
Enrollment
80
Registered
2026-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr. Vishwanath Wasedar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient undergoing classical virechana Patient undergoing classical virechana for rejuvenation therapy Patient having normal levels of lipid profiles within 30days of test Patients with BMI less 28kg m2 Patient undergoing classical virechana in Sharad kala Undergoing shodhananga snehapana with Murchita ghrita and Panchatikta guggulu ghrita Patients fit for Virechana

Exclusion criteria

Exclusion criteria: Known case of DM,CA, TB patients On dislipedemic medications Hypothyroidism patients Known case of Cushing Syndrome, Nephrotic Syndrome and Chronic kidney disease

Design outcomes

Primary

MeasureTime frame
There will be significant changes in inflammatory markers during shodhananga Snehapana with Moorchita ghrita and Pancha tiktaka guggulu ghrita.Timepoint: 0th day, 3rd to 7th day and 7th to 12th day—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr Vishwanath Wasedar

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya

drvswayurveda@gmail.com8494946898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026